Still's disease is an inflammatory disorder typically manifesting with fever, arthritis, and skin rash. It affects both children and adults, and has previously been known as systemic juvenile idiopathic arthritis and adult-onset Still's disease. Regardless of the name, people with Still's disease are burdened by life-threatening complications.
Researchers test the systemic score for Still's disease retrieved 12 June 2024 from https://medicalxpress.com/news/2024-06-score-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Anti-obesity jab ‘cuts risk of heart attack or stroke regardless of weight lost’A weekly dose of Wegovy, alongside standard care for the prevention of heart attacks or stroke, lowered the risk by 20% compared with those given a placebo.
Read more »
Obesity drug cuts risk of heart attack or stroke regardless of weight lost, study findsThe drug Wegovy uses an active ingredient called Semaglutide which is part of a growing class of GLP-1 drugs that make people feel full, reducing their calorie intake.
Read more »
Obesity drug cuts risk of heart attack or stroke 'regardless of weight lost’A weekly dose of Wegovy, alongside standard care for the prevention of heart attacks or stroke, lowered the risk by 20% compared with those given a placebo.
Read more »
Leeds United to receive bids for stars regardless of promotionThe inside track on the football stories that matter
Read more »
Tirzepatide treatment results in successful weight loss regardless of obesity-related complicationsHaving medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.
Read more »
Study finds methods to quit smoking effective regardless of mental health historySarah Jackson and colleagues from University College London and King's College London branches of the SPECTRUM Consortium conducted a survey to study how mental health relates to methods people use to quit smoking, also known as smoking cessation aids.
Read more »